PROGRAM

Evening of August 24, 2011 - The Residence of H.E. the U.S. Ambassador

5:30 p.m.

Welcoming Reception
Hosted by Chargé d' Affairs Laura Kirkconnell
Special Acknowledgement to Tomas Puusepp,
CEO, Elekta

Opening Remarks
Barbro C. Ehnbom,
Chairman, SALSS

Morning of August 25, 2011 - Ernst & Young Headquarters

8:15 a.m.

Registration & Breakfast

9:00 a.m.

Setting the Stage
Dr. Carl Johan Sundberg,
Head of Bioentrepreneurship, Karolinska Institutet

9:10 a.m.

Welcoming Remarks
Göran Hägglund,
Minister for Health & Social Affairs, Swedish Government

9:25 a.m.

Keynote Address: What to Expect in a Rapidly Changing Life Science World
Richard Bergström,
Director General, European Federation of Pharmaceutical Industries and Associations

9:45 a.m.

Building Pharma 3.0
Jürg Zürcher,
Partner & EMEIA Biotechnology Leader, Ernst & Young

10:00 a.m.

Company Presentations & Coffee
Algeta (Norway)
Viropro (U.S.A)
XDx (U.S.A)

11:00 a.m.

Panel: A Shifting Industry - Trends & Opportunities in the Coming Decade

Moderator: Dr. Stefan Larsson,
Senior Partner & Managing Director, The Boston Consulting Group

Dr. Håkan Åström,
Chairman, Orexo

Dr. Florence Haseltine,
Founder, Society for Women's Health Research

Professor Kee Seng Chia,
National University of Singapore

Patrick Flochel,
Partner & EMEIA Life Science Leader, Ernst & Young

Abe Kasbo,
CEO, Verasoni

Dr. Yuval Binur,
Managing General Partner, Accelerated Technologies Partners

12:00 noon

Luncheon
Hosted by Jan Birgerson,
CEO, Ernst & Young

Luncheon Adress
Ursula Tengelin,
Secretary General, Cancerfonden

1:30 p.m.

Building a Human Atlas to Identify Cancer Biomarkers
Professor Mathias Uhlén,
The Royal Institute of Technology

2:00 p.m.

Novel Approaches to Develop Cancer Treatments
Dr. Andrew Hessel,
Founding Director, Pink Army Cooperative

2:30 p.m.

Company Presentations & Coffee
Aura Biosciences (U.S.A)
Kancera (Sweden)
PledPharma (Sweden)

3:30 p.m.

Panel: Conquering Cancer Through the Convergence of Science & Engineering

Moderator: Dr. William A. Haseltine,
Founder, Haseltine Global Health

Professor Thomas Helleday,
Universities of Oxford & Stockholm

Dr. Elisabet de los Pinos,
CEO, Aura Biosciences

Mr. Tomas Puusepp,
CEO, Elekta

Evening of August 25, 2011 - The Boston Consulting Group Headquarters

6:00 p.m.

Rising Stars Reception
Hosted by Mr. Johan Öberg,
Partner and Managing Director, The Boston Consulting Group

AddBIO (Sweden)
Kalvista (UK)
NoseLabs (Sweden)
PCAsso Diagnostics (U.S.)
Pink Army (U.S.)
Xbrane (Sweden)

7:30 p.m.

Dinner Cruise on M/S Riddarfjärden
Hosted by Dr. Stefan Larsson,
Senior Partner & Managing Director, The Boston Consulting Group

Morning of August 26, 2011 - The Museum of Photography

8:15 a.m.

Registration & Breakfast

9:00 a.m.

Setting the Stage
Dr. Karin Hehenberger,
Senior Vice President, JDRF

9:10 a.m.

Special Guest: Ophthalmology's Shifting Role in Pharma Industry
Mr. Fred Hassan,
Chairman, Bausch + Lomb

9:30 a.m.

Panel: Trends in Ophthalmology

Moderator: Dr. Eugen Steiner,
Partner, HealthCap

Dr. Samir Tari,
CEO, PCAsso Diagnostics

Professor Jan Holgersson,
CSO, Recopharma

Dr. Karin Hehenberger,
Senior Vice President, JDRF

Mr. Fred Hassan,
Chairman, Bausch + Lomb

10:30 a.m.

Company Presentations & Coffee
IMMUNE Pharmaceuticals (Israel)
Recopharma (Sweden)
Topotarget (Denmark)

11:30 a.m.

Gateway to Europe - the Swedish MPA
Dr. Christina Åkerman,
Director General, Medical Products Agency

12:00 noon

Inspirational Speaker: Global Health
Professor Hans Rosling,
Karolinska Institutet

12:30 p.m.

Concluding Luncheon
Hosted by Mr. Lars Sjögren,
Deputy CEO, Danske Bank

Perspectives on SALSS 2011 & Introduction to SALSS 2012
Dr. William A. Haseltine,
Founder, Haseltine Global Health

2:00 p.m.

Special SALSS Exhibit: Through My Eyes - Project Playground, South Africa
Presented by Sofia Hellqvist and Frida Vesterberg